期刊文献+

小剂量肝素治疗重度子痫前期临床效果及对血清IL-10含量的影响 被引量:3

Clinical Effect of Low-dose Heparin in Treatment of Patients with Severe Pre-eclampsia and Its Influence on IL-10 in Serum
下载PDF
导出
摘要 目的探讨小剂量肝素对重度子痫前期治疗效果及对孕妇血清白细胞介素10(IL-10)水平的影响。方法选择我院收治的重度子痫前期40例,随机分为治疗组和对照组,每组20例。对照组予5%葡萄糖注射液1000 ml+25%硫酸镁60 ml,每日1次维持静脉滴注;治疗组在此基础上加用肝素25 mg,每日1次维持静脉滴注6~8 h。监测两组平均动脉压、尿量、红细胞压积、产后出血及孕产妇、新生儿预后,并监测两组孕妇血清IL-10的含量。结果治疗后两组平均动脉压、红细胞压积、尿量均较治疗前明显改善,差异均有统计学意义(P〈0.05),治疗组各指标改善情况优于对照组,差异均有统计学意义(P〈0.05)。两组产后出血、新生儿Apgar评分0~3分及孕周延长致35周以上分娩的发生率比较差异无统计学意义(P〉0.05),治疗组新生儿Apgar评分4~7分发生率为10%,对照组为30%,差异有统计学意义(P〈0.05)。治疗组治疗前后IL-10分别为(3.8±1.1)pg/ml、(5.7±0.7)pg/ml,对照组分别为(3.9±0.9)pg/ml、(4.0±0.7)pg/ml。两组治疗前比较差异无统计学意义(P〉0.05);治疗后治疗组IL-10明显高于治疗前及对照组,差异均有统计学意义(P〈0.05);对照组治疗后血清IL-10含量升高,但与治疗前比较差异无统计学意义(P〉0.05)。结论小剂量肝素治疗重度子痫前期能升高血清IL-10含量,提示肝素能通过抑制炎性反应达到治疗重度子痫前期的作用。 Objective To discuss the clinical effects of low-dose heparin in the treatment of patients with severe pre-eclampsia and its influence on IL-10 in serum.Methods 40 patients with severe pre-eclampsia in our hospital were randomly divided into treatment group and control group with 20 patients in each group.The control group received 5% glucose injection(1000 ml) +25% magnesium sulfate(60 ml),and were kept to intravenous infusion once a day;the treatment group was added with heparin 25 mg based on the treatment of control group and kept to intravenous infusion 6 to 8 h once a day.The mean arterial pressure,urine volume,hematocrit and serum IL-10 content of the two groups were detected,and postpartum hemorrhage,maternal and neonatal prognosis were observed.Results The mean arterial pressure,hematocrit and urine volume in the two groups significantly improved when compared with that before treatment,and the difference was statistically significant(P0.05),and the improvement in the treatment group was better than that in the control group,and the difference was statistically significant(P0.05).There was no statistically significant difference of the incidence of postpartum hemorrhage,neonatal Apgar score with 0 to 3 and parturition in more than 35 weeks gestation between the two groups(P0.05);the rate of neonatal with Apgar score 4 to 7 in the treatment group was 10%,but 30% in the control group,and the difference was statistically significant(P0.05).Serum IL-10 contents in the treatment group were(3.8±1.1) pg/ml before treatment and(5.7± 0.7) pg/ml after treatment,but in control group they were(3.9± 0.9) pg/ml and(4.0± 0.7) pg/ml respectively.Comparison of IL-10 content of the two groups showed no significant differences before treatment(P0.05),but in the treatment group IL-10 content after treatment was significantly higher than that before treatment and also higher than that in the control group and the difference was statistically significant(P0.05);IL-10 content in the control group increased after treatment,but it showed no statistically significant difference(P0.05).Conclusion Low-dose heparin in the treatment of severe pre-eclampsia can increase serum IL-10 content,which suggests that heparin may inhibit the inflammatory response which may be significant in the treatment of severe preeclampsia.
出处 《临床误诊误治》 2010年第12期1119-1121,共3页 Clinical Misdiagnosis & Mistherapy
关键词 肝素 硫酸镁 子痫 妊娠并发症 白细胞介素10 Heparin Magnesium sulfate Eclampsia Pregnancy complications Interleukin-10
  • 相关文献

参考文献10

  • 1Merviel P,Evain-Brion D,Challier J C,et al.The molecular basis of embryo implantation in humans[J].entralbl-Gynakol,2001,123(6):328-339.
  • 2Xie X,Rivier A S,Zakrzewicz A,et al.Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides.Studies with carboxyl-reduced and sulfated heparin and with trestatin a sulfate[J].J Biol Chem,2000,275(44):34818-34825.
  • 3Reister F,Frank H G,Kingdom J C,et al.Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women[J].Lab Invest,2001,81(8):1143-1152.
  • 4Bobek V,Boubelik M,Fiserova A,et al.Anticoagulant drugs increase natural killer cell activity in lung cancer[J].Lung Cancer,2005,47(2):215-223.
  • 5Rein D T,Breidenbach M,Honscheid B,et al.Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro[J].Cytokine,2003,23(45):119-125.
  • 6杨颖,李国芸,毕冬华.重度子痫前期96例临床特征及并发症分析[J].临床误诊误治,2010,23(2):110-111. 被引量:12
  • 7王海燕.成功救治子痫合并HELLP综合征和脑静脉窦血栓形成[J].临床误诊误治,2007,20(10):50-50. 被引量:1
  • 8王锋,汪年松,晏春根.肝素对内皮细胞黏附功能的影响[J].中国急救医学,2005,25(11):813-815. 被引量:5
  • 9Shapira O M,Rene H,Lider O,et al.Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin[J].J Surg Res,1999,85(1):83-87.
  • 10Ozawa T,Yoshihara K,Koyama N,et al.Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children[J].Ann Thorac Surg,2000,69(2):584-590.

二级参考文献26

  • 1杨孜.早发型重度先兆子痫——产科医师面临的挑战[J].中国妇产科临床杂志,2003,4(2):83-84. 被引量:125
  • 2段玉梅.重度妊娠423例高血压综合征终止妊娠时间分析[J].中国误诊学杂志,2004,4(6):876-877. 被引量:38
  • 3罗绮薇.重度子前期经阴道分娩58例临床分析[J].临床误诊误治,2005,18(6):423-424. 被引量:3
  • 4苟文丽.妊娠期高血压疾病[M]//乐杰.妇产科学.6版.北京:人民卫生出版社,2004:97-104.
  • 5Blackwell S C, Redman M E, Tnmlinson M, et al. Severe pre-eelampsia remote from term: what to expect of expectant management[ J]. J Matern Fetal Neonatal Med, 2002, 11 (5) :321-324.
  • 6Hall D R, Odendaal H J, Steyn D W, et al. Expectant management of early onset, severe pre-eclampsia : maternal outcome[J]. BJOG, 2000,107(10) :1252-1257.
  • 7Yao L, Pan J, Setiadi H, et al. Interleukin 4 or oncostatin M induces a prolonged increase in P- selectin mRNA and protein in human endothelial cells[J] .J Exp Med, 1996,184( 1 ) :81 - 92.
  • 8Pan J, Xia L, Yao L, et al. Tumor necrosis factor- alpha- or lipopolysaccharide - induced expression of the murine P - selectin gene in endothelial cells involves novel kappaB sites and a variant activating transcription factor/cAMP response element[J] .J Biol Chem, 1998,273 (16):10068- 10077.
  • 9Pan J, Xia L, McEver RP. Comparison of promoters for the murine and human P - selectin genes suggests species - specilic and conserved mechanisms for transcriptional regulation in endothelial cells [ J ]. J Biol Chem, 1998,273(16): 10058 - 10067.
  • 10杨景山.中性粒细胞的分离[M]..医学细胞化学与细胞生物技术[C].北京:北京医科大学中国协和医科大学联合出版社,1990.17-18.

共引文献15

同被引文献46

  • 1杨孜,林其德.子痫前期-子痫的病理生理学研究[J].中华妇产科杂志,2006,41(8):507-508. 被引量:27
  • 2乐杰.妇产科学[M].第7版.北京:人民卫生出版社,2011:278-84.
  • 3Coomarasamy A,Honest H,Papaioannou S,et al.Aspiirn for prevention of preeclampsia in women with historical risk factors:a systemic review[J].Obstet Gynecol,2003,101(6):1319-1332.
  • 4Kupfermine M,Rimon E,Many A,et al.Low molecular weight heparin versus no treatment in women with previous severe pregnna cy complicaitons and placental findings without thrombophilia[J].Blood Coagul Fibrinolysis,2011,22(2):123-126.
  • 5Panni JK,Panni MK.Obstetric patient on Lovenox therapy:evidence of hepaifn activity at 24 hours[J].J Obstet Gynaeeol,2010,30(1):62-64.
  • 6卢莉萍,李忠祥,戴淑玲,臧玉芹,高翠美.低分子肝素对重度子痫前期患者肾功能保护作用的临床探讨[J].中国妇产科临床杂志,2007,8(6):423-425. 被引量:25
  • 7Atis A,Aydin Y,Basol E,et al.Troponin I and homocysteine levels in mild and severe preeclampsia[J].Clin Exp Obstet Gynecol,2010,37(1):21-23.
  • 8Dekker GA,de Vries JI,Doelitzsch PM,et al.Underlying disorders associated with severe early-onsetpreeclampsia[J].American journal of obstetrics and gynecology,1995,173(4):1042-1048.
  • 9SG.Cochrane handbook for systematic reviews of interventions version 5.1.0[M].The Cochrane Collaboration,2011.
  • 10马丽.31例重度子痫前期应用低分子肝素结合常规疗法疗效探讨[J].中国医药指南,2010,8(14):279-281.

引证文献3

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部